Search

Your search keyword '"Rebecca C. Spillmann"' showing total 53 results

Search Constraints

Start Over You searched for: Author "Rebecca C. Spillmann" Remove constraint Author: "Rebecca C. Spillmann"
53 results on '"Rebecca C. Spillmann"'

Search Results

1. Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy

2. Characteristics of undiagnosed diseases network applicants: implications for referring providers

3. A window into living with an undiagnosed disease: illness narratives from the Undiagnosed Diseases Network

4. Exome/Genome Sequencing in Undiagnosed Syndromes

5. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

6. An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome

7. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

8. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

9. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

10. A concurrent dual analysis of genomic data augments diagnoses: experiences of two clinical sites in the Undiagnosed Diseases Network

11. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

12. One is the loneliest number: genotypic matchmaking using the electronic health record

13. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

14. Early infantile epileptic encephalopathy due to biallelic pathogenic variants in <scp> PIGQ </scp> : Report of seven new subjects and review of the literature

15. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder

16. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

17. Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome

18. Clinical Application of a Scale to Assess Genomic Healthcare Empowerment (GEmS): Process and Illustrative Case Examples

19. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

20. Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies

21. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

22. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

23. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

24. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

25. Pathogenic SPTBN1 variants cause a novel autosomal dominant neurodevelopmental syndrome

26. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor beta Signaling

27. GATAD2B-associated neurodevelopmental disorder (GAND) : clinical and molecular insights into a NuRD-related disorder

28. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

29. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

30. The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease

31. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay

32. A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3

33. The Genome Empowerment Scale (GEmS): An Assessment of Parental Empowerment in Families with Undiagnosed Disease

34. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

35. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

36. Identification of Pathogenic Structural Variants in Rare Disease Patients through Genome Sequencing

37. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing

38. IRF2BPL Is Associated with Neurological Phenotypes

39. A Comprehensive Iterative Approach is Highly Effective in Diagnosing Individuals who are Exome Negative

40. Loss-of-function in IRF2BPL is associated with neurological phenotypes

41. Further evidence for the involvement of

42. Quinidine in the treatment of KCNT1-positive epilepsies

43. Psychosocial Profiles of Parents of Children with Undiagnosed Diseases: Managing Well or Just Managing?

44. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases

45. MARRVEL: Integration of Human and Model Organism Genetic Resources to Facilitate Functional Annotation of the Human Genome

46. Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ2 gain-of-function variants R201C and R201H

47. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype

48. Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders

49. Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios

50. Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes

Catalog

Books, media, physical & digital resources